Eterna Therapeutics
ERNA
#11154
Rank
S$3.55 M
Marketcap
S$2.10
Share price
0.62%
Change (1 day)
15.79%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): S-$37.47

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is S-$37.77. In 2022 the company made an earnings per share (EPS) of S-$4,057 an increase over its 2021 EPS that were of S-$26,806.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$37.47
2022S-$4,057-84.86%
2021S-$26,806

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
S$2.55-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
S-$1.82-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
S$2.21-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S-$0.10-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
S$0.58-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
S$1.51-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA